Cargando…

Cerebral Microbleeds, Cerebrospinal Fluid, and Neuroimaging Markers in Clinical Subtypes of Alzheimer's Disease

Lobar cerebral microbleeds (CMBs) in Alzheimer's disease (AD) are associated with cerebral amyloid angiopathy (CAA) due to vascular amyloid beta (Aβ) deposits. However, the relationship between lobar CMBs and clinical subtypes of AD remains unknown. Here, we enrolled patients with early- and la...

Descripción completa

Detalles Bibliográficos
Autores principales: Ikeda, Masaki, Kodaira, Sayaka, Kasahara, Hiroo, Takai, Eriko, Nagashima, Kazuaki, Fujita, Yukio, Makioka, Kouki, Hirayanagi, Kimitoshi, Furuta, Natsumi, Furuta, Minori, Sanada, Etsuko, Kobayashi, Ayumi, Harigaya, Yasuo, Nagamine, Shun, Hattori, Noriaki, Tashiro, Yuichi, Kishi, Kazuhiro, Shimada, Hirotaka, Suto, Takayuki, Tanaka, Hisashi, Sakai, Yasujiro, Yamazaki, Tsuneo, Tanaka, Yukiko, Aihara, Yuko, Amari, Masakuni, Yamaguchi, Haruyasu, Okamoto, Koichi, Takatama, Masamitsu, Ishii, Kenji, Higuchi, Tetsuya, Tsushima, Yoshito, Ikeda, Yoshio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056016/
https://www.ncbi.nlm.nih.gov/pubmed/33889121
http://dx.doi.org/10.3389/fneur.2021.543866
_version_ 1783680563972931584
author Ikeda, Masaki
Kodaira, Sayaka
Kasahara, Hiroo
Takai, Eriko
Nagashima, Kazuaki
Fujita, Yukio
Makioka, Kouki
Hirayanagi, Kimitoshi
Furuta, Natsumi
Furuta, Minori
Sanada, Etsuko
Kobayashi, Ayumi
Harigaya, Yasuo
Nagamine, Shun
Hattori, Noriaki
Tashiro, Yuichi
Kishi, Kazuhiro
Shimada, Hirotaka
Suto, Takayuki
Tanaka, Hisashi
Sakai, Yasujiro
Yamazaki, Tsuneo
Tanaka, Yukiko
Aihara, Yuko
Amari, Masakuni
Yamaguchi, Haruyasu
Okamoto, Koichi
Takatama, Masamitsu
Ishii, Kenji
Higuchi, Tetsuya
Tsushima, Yoshito
Ikeda, Yoshio
author_facet Ikeda, Masaki
Kodaira, Sayaka
Kasahara, Hiroo
Takai, Eriko
Nagashima, Kazuaki
Fujita, Yukio
Makioka, Kouki
Hirayanagi, Kimitoshi
Furuta, Natsumi
Furuta, Minori
Sanada, Etsuko
Kobayashi, Ayumi
Harigaya, Yasuo
Nagamine, Shun
Hattori, Noriaki
Tashiro, Yuichi
Kishi, Kazuhiro
Shimada, Hirotaka
Suto, Takayuki
Tanaka, Hisashi
Sakai, Yasujiro
Yamazaki, Tsuneo
Tanaka, Yukiko
Aihara, Yuko
Amari, Masakuni
Yamaguchi, Haruyasu
Okamoto, Koichi
Takatama, Masamitsu
Ishii, Kenji
Higuchi, Tetsuya
Tsushima, Yoshito
Ikeda, Yoshio
author_sort Ikeda, Masaki
collection PubMed
description Lobar cerebral microbleeds (CMBs) in Alzheimer's disease (AD) are associated with cerebral amyloid angiopathy (CAA) due to vascular amyloid beta (Aβ) deposits. However, the relationship between lobar CMBs and clinical subtypes of AD remains unknown. Here, we enrolled patients with early- and late-onset amnestic dominant AD, logopenic variant of primary progressive aphasia (lvPPA) and posterior cortical atrophy (PCA) who were compatible with the AD criteria. We then examined the levels of cerebrospinal fluid (CSF) biomarkers [Aβ1-42, Aβ1-40, Aβ1-38, phosphorylated tau 181 (P-Tau), total tau (T-Tau), neurofilament light chain (NFL), and chitinase 3-like 1 protein (YKL-40)], analyzed the number and localization of CMBs, and measured the cerebral blood flow (CBF) volume by (99m)Tc-ethyl cysteinate dimer single photon emission computerized tomography ((99m)Tc ECD-SPECT), as well as the mean cortical standard uptake value ratio by (11)C-labeled Pittsburgh Compound B-positron emission tomography ((11)C PiB-PET). Lobar CMBs in lvPPA were distributed in the temporal, frontal, and parietal lobes with the left side predominance, while the CBF volume in lvPPA significantly decreased in the left temporal area, where the number of lobar CMBs and the CBF volumes showed a significant inversely correlation. The CSF levels of NFL in lvPPA were significantly higher compared to the other AD subtypes and non-demented subjects. The numbers of lobar CMBs significantly increased the CSF levels of NFL in the total AD patients, additionally, among AD subtypes, the CSF levels of NFL in lvPPA predominantly were higher by increasing number of lobar CMBs. On the other hand, the CSF levels of Aβ1-38, Aβ1-40, Aβ1-42, P-Tau, and T-Tau were lower by increasing number of lobar CMBs in the total AD patients. These findings may suggest that aberrant brain hypoperfusion in lvPPA was derived from the brain atrophy due to neurodegeneration, and possibly may involve the aberrant microcirculation causing by lobar CMBs and cerebrovascular injuries, with the left side dominance, consequently leading to a clinical phenotype of logopenic variant.
format Online
Article
Text
id pubmed-8056016
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-80560162021-04-21 Cerebral Microbleeds, Cerebrospinal Fluid, and Neuroimaging Markers in Clinical Subtypes of Alzheimer's Disease Ikeda, Masaki Kodaira, Sayaka Kasahara, Hiroo Takai, Eriko Nagashima, Kazuaki Fujita, Yukio Makioka, Kouki Hirayanagi, Kimitoshi Furuta, Natsumi Furuta, Minori Sanada, Etsuko Kobayashi, Ayumi Harigaya, Yasuo Nagamine, Shun Hattori, Noriaki Tashiro, Yuichi Kishi, Kazuhiro Shimada, Hirotaka Suto, Takayuki Tanaka, Hisashi Sakai, Yasujiro Yamazaki, Tsuneo Tanaka, Yukiko Aihara, Yuko Amari, Masakuni Yamaguchi, Haruyasu Okamoto, Koichi Takatama, Masamitsu Ishii, Kenji Higuchi, Tetsuya Tsushima, Yoshito Ikeda, Yoshio Front Neurol Neurology Lobar cerebral microbleeds (CMBs) in Alzheimer's disease (AD) are associated with cerebral amyloid angiopathy (CAA) due to vascular amyloid beta (Aβ) deposits. However, the relationship between lobar CMBs and clinical subtypes of AD remains unknown. Here, we enrolled patients with early- and late-onset amnestic dominant AD, logopenic variant of primary progressive aphasia (lvPPA) and posterior cortical atrophy (PCA) who were compatible with the AD criteria. We then examined the levels of cerebrospinal fluid (CSF) biomarkers [Aβ1-42, Aβ1-40, Aβ1-38, phosphorylated tau 181 (P-Tau), total tau (T-Tau), neurofilament light chain (NFL), and chitinase 3-like 1 protein (YKL-40)], analyzed the number and localization of CMBs, and measured the cerebral blood flow (CBF) volume by (99m)Tc-ethyl cysteinate dimer single photon emission computerized tomography ((99m)Tc ECD-SPECT), as well as the mean cortical standard uptake value ratio by (11)C-labeled Pittsburgh Compound B-positron emission tomography ((11)C PiB-PET). Lobar CMBs in lvPPA were distributed in the temporal, frontal, and parietal lobes with the left side predominance, while the CBF volume in lvPPA significantly decreased in the left temporal area, where the number of lobar CMBs and the CBF volumes showed a significant inversely correlation. The CSF levels of NFL in lvPPA were significantly higher compared to the other AD subtypes and non-demented subjects. The numbers of lobar CMBs significantly increased the CSF levels of NFL in the total AD patients, additionally, among AD subtypes, the CSF levels of NFL in lvPPA predominantly were higher by increasing number of lobar CMBs. On the other hand, the CSF levels of Aβ1-38, Aβ1-40, Aβ1-42, P-Tau, and T-Tau were lower by increasing number of lobar CMBs in the total AD patients. These findings may suggest that aberrant brain hypoperfusion in lvPPA was derived from the brain atrophy due to neurodegeneration, and possibly may involve the aberrant microcirculation causing by lobar CMBs and cerebrovascular injuries, with the left side dominance, consequently leading to a clinical phenotype of logopenic variant. Frontiers Media S.A. 2021-04-06 /pmc/articles/PMC8056016/ /pubmed/33889121 http://dx.doi.org/10.3389/fneur.2021.543866 Text en Copyright © 2021 Ikeda, Kodaira, Kasahara, Takai, Nagashima, Fujita, Makioka, Hirayanagi, Furuta, Furuta, Sanada, Kobayashi, Harigaya, Nagamine, Hattori, Tashiro, Kishi, Shimada, Suto, Tanaka, Sakai, Yamazaki, Tanaka, Aihara, Amari, Yamaguchi, Okamoto, Takatama, Ishii, Higuchi, Tsushima and Ikeda. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Ikeda, Masaki
Kodaira, Sayaka
Kasahara, Hiroo
Takai, Eriko
Nagashima, Kazuaki
Fujita, Yukio
Makioka, Kouki
Hirayanagi, Kimitoshi
Furuta, Natsumi
Furuta, Minori
Sanada, Etsuko
Kobayashi, Ayumi
Harigaya, Yasuo
Nagamine, Shun
Hattori, Noriaki
Tashiro, Yuichi
Kishi, Kazuhiro
Shimada, Hirotaka
Suto, Takayuki
Tanaka, Hisashi
Sakai, Yasujiro
Yamazaki, Tsuneo
Tanaka, Yukiko
Aihara, Yuko
Amari, Masakuni
Yamaguchi, Haruyasu
Okamoto, Koichi
Takatama, Masamitsu
Ishii, Kenji
Higuchi, Tetsuya
Tsushima, Yoshito
Ikeda, Yoshio
Cerebral Microbleeds, Cerebrospinal Fluid, and Neuroimaging Markers in Clinical Subtypes of Alzheimer's Disease
title Cerebral Microbleeds, Cerebrospinal Fluid, and Neuroimaging Markers in Clinical Subtypes of Alzheimer's Disease
title_full Cerebral Microbleeds, Cerebrospinal Fluid, and Neuroimaging Markers in Clinical Subtypes of Alzheimer's Disease
title_fullStr Cerebral Microbleeds, Cerebrospinal Fluid, and Neuroimaging Markers in Clinical Subtypes of Alzheimer's Disease
title_full_unstemmed Cerebral Microbleeds, Cerebrospinal Fluid, and Neuroimaging Markers in Clinical Subtypes of Alzheimer's Disease
title_short Cerebral Microbleeds, Cerebrospinal Fluid, and Neuroimaging Markers in Clinical Subtypes of Alzheimer's Disease
title_sort cerebral microbleeds, cerebrospinal fluid, and neuroimaging markers in clinical subtypes of alzheimer's disease
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056016/
https://www.ncbi.nlm.nih.gov/pubmed/33889121
http://dx.doi.org/10.3389/fneur.2021.543866
work_keys_str_mv AT ikedamasaki cerebralmicrobleedscerebrospinalfluidandneuroimagingmarkersinclinicalsubtypesofalzheimersdisease
AT kodairasayaka cerebralmicrobleedscerebrospinalfluidandneuroimagingmarkersinclinicalsubtypesofalzheimersdisease
AT kasaharahiroo cerebralmicrobleedscerebrospinalfluidandneuroimagingmarkersinclinicalsubtypesofalzheimersdisease
AT takaieriko cerebralmicrobleedscerebrospinalfluidandneuroimagingmarkersinclinicalsubtypesofalzheimersdisease
AT nagashimakazuaki cerebralmicrobleedscerebrospinalfluidandneuroimagingmarkersinclinicalsubtypesofalzheimersdisease
AT fujitayukio cerebralmicrobleedscerebrospinalfluidandneuroimagingmarkersinclinicalsubtypesofalzheimersdisease
AT makiokakouki cerebralmicrobleedscerebrospinalfluidandneuroimagingmarkersinclinicalsubtypesofalzheimersdisease
AT hirayanagikimitoshi cerebralmicrobleedscerebrospinalfluidandneuroimagingmarkersinclinicalsubtypesofalzheimersdisease
AT furutanatsumi cerebralmicrobleedscerebrospinalfluidandneuroimagingmarkersinclinicalsubtypesofalzheimersdisease
AT furutaminori cerebralmicrobleedscerebrospinalfluidandneuroimagingmarkersinclinicalsubtypesofalzheimersdisease
AT sanadaetsuko cerebralmicrobleedscerebrospinalfluidandneuroimagingmarkersinclinicalsubtypesofalzheimersdisease
AT kobayashiayumi cerebralmicrobleedscerebrospinalfluidandneuroimagingmarkersinclinicalsubtypesofalzheimersdisease
AT harigayayasuo cerebralmicrobleedscerebrospinalfluidandneuroimagingmarkersinclinicalsubtypesofalzheimersdisease
AT nagamineshun cerebralmicrobleedscerebrospinalfluidandneuroimagingmarkersinclinicalsubtypesofalzheimersdisease
AT hattorinoriaki cerebralmicrobleedscerebrospinalfluidandneuroimagingmarkersinclinicalsubtypesofalzheimersdisease
AT tashiroyuichi cerebralmicrobleedscerebrospinalfluidandneuroimagingmarkersinclinicalsubtypesofalzheimersdisease
AT kishikazuhiro cerebralmicrobleedscerebrospinalfluidandneuroimagingmarkersinclinicalsubtypesofalzheimersdisease
AT shimadahirotaka cerebralmicrobleedscerebrospinalfluidandneuroimagingmarkersinclinicalsubtypesofalzheimersdisease
AT sutotakayuki cerebralmicrobleedscerebrospinalfluidandneuroimagingmarkersinclinicalsubtypesofalzheimersdisease
AT tanakahisashi cerebralmicrobleedscerebrospinalfluidandneuroimagingmarkersinclinicalsubtypesofalzheimersdisease
AT sakaiyasujiro cerebralmicrobleedscerebrospinalfluidandneuroimagingmarkersinclinicalsubtypesofalzheimersdisease
AT yamazakitsuneo cerebralmicrobleedscerebrospinalfluidandneuroimagingmarkersinclinicalsubtypesofalzheimersdisease
AT tanakayukiko cerebralmicrobleedscerebrospinalfluidandneuroimagingmarkersinclinicalsubtypesofalzheimersdisease
AT aiharayuko cerebralmicrobleedscerebrospinalfluidandneuroimagingmarkersinclinicalsubtypesofalzheimersdisease
AT amarimasakuni cerebralmicrobleedscerebrospinalfluidandneuroimagingmarkersinclinicalsubtypesofalzheimersdisease
AT yamaguchiharuyasu cerebralmicrobleedscerebrospinalfluidandneuroimagingmarkersinclinicalsubtypesofalzheimersdisease
AT okamotokoichi cerebralmicrobleedscerebrospinalfluidandneuroimagingmarkersinclinicalsubtypesofalzheimersdisease
AT takatamamasamitsu cerebralmicrobleedscerebrospinalfluidandneuroimagingmarkersinclinicalsubtypesofalzheimersdisease
AT ishiikenji cerebralmicrobleedscerebrospinalfluidandneuroimagingmarkersinclinicalsubtypesofalzheimersdisease
AT higuchitetsuya cerebralmicrobleedscerebrospinalfluidandneuroimagingmarkersinclinicalsubtypesofalzheimersdisease
AT tsushimayoshito cerebralmicrobleedscerebrospinalfluidandneuroimagingmarkersinclinicalsubtypesofalzheimersdisease
AT ikedayoshio cerebralmicrobleedscerebrospinalfluidandneuroimagingmarkersinclinicalsubtypesofalzheimersdisease